Chemistry Professor at Freie Universität Berlin Rainer Haag Receives Prestigious Grant
en-GBde-DEes-ESfr-FR

Chemistry Professor at Freie Universität Berlin Rainer Haag Receives Prestigious Grant


The Novo Nordisk Foundation has awarded a two-million-dollar grant to support the development of new influenza virus blockers

The Novo Nordisk Foundation has awarded an international research team led by Professor Rainer Haag a grant worth two million US dollars to support the development of precision glycol-oligomers as hetero-multivalent pandemic influenza virus blockers.

The influenza A virus (IAV) anchors to host cell surfaces with different surface proteins to initiate the infection cycle. These surface proteins are responsible for virus adhesion to host cells and the release of newly produced viruses. In this project the investigators will aim to mimic the host cells by using similar receptor molecules displayed on a multivalent scaffold but arranged with high precision to “trick” the virus and efficiently block infection. The project focuses on the precise design of affordable multivalent scaffolds that carry different virus-binding receptor molecules to block virus surface proteins and arrest the infection cycle. If successful, the resulting drug candidate will provide a new approach to target pandemic IAV strains, prevent resistance, and contribute to preparedness for future influenza pandemics.

The researchers behind the project complement each other’s expertise on multivalent scaffolds, nucleic acid technology, glycoconjugates, in vitro binding assays, and IAV in vivo models. The consortium consists of Rainer Haag and his research group at Freie Universität Berlin; collaborators Jørgen Kjems and Julián Valero Moreno and their research groups at Aarhus University, Denmark; Wendy Barclay and her research group at Imperial College of London, United Kingdom; and Sumati Bhatia and her research group at Swansea University, United Kingdom. The three-year project will commence in spring 2024.

Regions: North America, United States, Europe, Denmark, Germany, United Kingdom
Keywords: Science, Grants & new facilities, Life Sciences

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
Copyright 2024 by AlphaGalileo Terms Of Use Privacy Statement